Recent Developments of Protein Kinase Inhibitors as Potential AD Therapeutics

Present AD therapies suffer from inefficient effects on AD symptoms like memory or cognition, especially in later states of the disease. Used acteylcholine esterase (ACE) inhibitors or the NMDA receptor antagonist memantine address one target structure which is involved in a complex, multifactorial...

Full description

Bibliographic Details
Main Authors: Andreas eHilgeroth, Volkmar eTell
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-11-01
Series:Frontiers in Cellular Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fncel.2013.00189/full

Similar Items